Coldstream Capital Management Inc Genmab A/S Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Genmab A/S stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,766 shares of GMAB stock, worth $55,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,766Holding current value
$55,126% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
253Shares Held
60.8MCall Options Held
182KPut Options Held
70.4K-
Alliancebernstein L.P. New York, NY14.9MShares$298 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D05.71MShares$114 Million0.8% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$101 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$61.6 Million0.01% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$57.4 Million0.45% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.1B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...